Business
Fleury: Strong growth, expanded reach, and robust ESG drive leadership in Brazilian diagnostic medicine
Fleury: Strong growth, expanded reach, and robust ESG drive leadership in Brazilian diagnostic medicine
About this update from Fleury Sa
A leading diagnostic medicine provider in Brazil, the group has expanded through acquisitions and the Pardini merger, boosting its national reach and service portfolio. Financials show strong revenue and EBITDA growth, while ESG efforts focus on environmental impact, healthcare access, and governance excellence.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.